Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO19123 Cream in Atopic Dermatitis
NCT00392067Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of LEO80122 in atopic dermatitis (AD) (3 arms), sponsored by LEO Pharma. Primary endpoint: Proof of concept. Started Oct 2006; status: completed.
02
Drugs
LEO80122
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00392067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392067.